Patient characteristics | Pre implementation (N=75) | Post implementation (N=61) | P value |
Index event | |||
% Admitted for index event (n) | 68.0 (51) | 70.5 (43) | 0.853 |
% Weekend presentation (n) | 17.3 (13) | 21.3 (13) | 0.662 |
Demographics | |||
Mean age in years (SD) | 66.2 (10.3) | 67.7 (11.9) | 0.444 |
Median age (range) | 66 (39–95) | 68 (33–95) | 0.342 |
Race | 0.377 | ||
% White (n) | 81.3 (61) | 75.4 (46) | |
% Black (n) | 14.7 (11) | 23.0 (14) | |
% Asian (n) | 0.0 (0) | 0.0 (0) | |
% Other (n) | 0.0 (0) | 0.0 (0) | |
% Unknown (n) | 4.0 (3) | 1.6 (1) | |
% Hispanic ethnicity (n) | 1.3 (1) | 0.0 (0) | 1.000 |
Past medical history | |||
% Prior transient ischaemic attacks (n) | 61.3 (46) | 60.7 (37) | 1.000 |
% Prior stroke (n) | 18.7 (14) | 13.1 (8) | 0.484 |
% Diabetes mellitus (n) | 44.0 (33) | 36.1 (22) | 0.383 |
% Atrial fibrillation (n) | 6.7 (5) | 14.8 (9) | 0.159 |
% Myocardial infarction (n) | 2.7 (2) | 1.6 (1) | 1.000 |
% CABG, PTCA/PCI (n) | 1.3 (1) | 0.0 (0) | 1.000 |
% Congestive heart failure (n) | 10.7 (8) | 16.4 (10) | 0.446 |
% Pacemaker or AICD (n) | 6.7 (5) | 4.9 (3) | 0.731 |
% Valvular heart disease: native or mechanical (n) | 1.3 (1) | 4.9 (3) | 0.325 |
% CEA, carotid stent (n) | 1.3 (1) | 0.0 (0) | 1.000 |
% COPD (n) | 13.3 (10) | 18.0 (11) | 0.482 |
% PVD (n) | 10.7 (8) | 9.8 (6) | 1.000 |
% Dementia (n) | 6.7 (5) | 11.5 (7) | 0.373 |
% CKD (n) | 14.7 (11) | 18.0 (11) | 0.644 |
% Dialysis (n) | 1.3 (1) | 0.0 (0) | 1.000 |
% Cancer (n) | 6.7 (5) | 13.1 (8) | 0.248 |
% Hypertension (n) | 66.7 (50) | 72.1 (44) | 0.577 |
% Hyperlipidaemia (n) | 58.7 (44) | 67.2 (41) | 0.374 |
% Arrhythmia (n) | 5.3 (4) | 3.3 (2) | 0.691 |
% Speech deficit (n) | 4.0 (3) | 9.8 (6) | 0.298 |
% Motor deficit, hemiplegia (n) | 6.7 (5) | 23.0 (14) | 0.011 |
% Sleep apnea (n) | 20.0 (15) | 39.3 (24) | 0.022 |
% Alcohol dependence (n) | 2.7 (2) | 4.9 (3) | 0.657 |
% Depression (n) | 14.7 (11) | 32.8 (20) | 0.014 |
% Liver disease (n) | 2.7 (2) | 6.6 (4) | 0.408 |
% History of VTE: deep vein thrombosis, PE (n) | 0.0 (0) | 4.9 (3) | 0.088 |
% Any major bleeding: emergency department, inpatient admission for bleeding (n) | 0.0 (0) | 1.6 (1) | 0.449 |
% Intracranial haemorrhage (n) | 2.7 (2) | 4.9 (3) | 0.657 |
% Migraine (n) | 0.0 (0) | 4.9 (3) | 0.088 |
Baseline medications prior to index event | |||
% Statin (n) | 60.0 (45) | 75.4 (46) | 0.068 |
% Aspirin (n) | 58.7 (44) | 59.0 (36) | 1.000 |
% Warfarin (n) | 1.3 (1) | 8.2 (5) | 0.090 |
% Anticoagulant (n) | 6.7 (5) | 18.0 (11) | 0.060 |
% Clopidogrel (n) | 6.7 (5) | 9.8 (6) | 0.541 |
% Any antithrombotic (n) | 64.0 (48) | 68.9 (42) | 0.589 |
Mean CHADVASC (SD) | 2.8 (1.4) | 3.0 (1.4) | 0.648 |
Mean HASBLED (SD) | 2.0 (1.2) | 2.2 (1.1) | 0.242 |
Charlson: mean±SD | 2.6 (2.3) | 2.8 (2.6) | 0.515 |
Median Charlson (range) | 2 (0–9) | 3 (0–14) | 0.563 |
% Smoker (n) | 41.3 (31) | 21.3 (13) | 0.017 |
AICD, automatic implantable cardioverter-defibrillator ; CABG, coronary artery bypass grafting; CEA, carotid endarterectomy; CHADVASC, score that includes congestive heart failure, hypertension, age >75, diabetes, prior stroke or TIA ; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HASBLED, Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly; PCI, percutaneous coronary intervention; PCTA, percutaneous transluminal coronary angioplasty; PE, pulmonary embolism; PVD, peripheral vascular disease; VTE, venous thromboembolism .